Dr. E. Anders Kolb received his medical degree from Thomas Jefferson University in Philadelphia. He completed pediatric residency training at St. Christopher’s Hospital for Children and fellowship training in hematology/oncology in the Department of Pediatrics at Memorial Sloan-Kettering Cancer Center. He is Professor of Pediatrics at Sidney Kimmel Medical College at Thomas Jefferson University, and the Director at Nemours Center for Cancer and Blood Disorders, Wilmington, Delaware, one of the top U.S. children’s hospitals for pediatric oncology and hematology.

Dr. Kolb is certified by the American Board of Pediatrics and its sub-board in pediatric hematology/oncology. A national leader in the Children’s Oncology Group (COG), chairing its Myeloid Disease Committee and serving on its Scientific Council and Bone Tumor Committee, Dr. Kolb is also a member of COG’s Scientific Council. In addition, he is a member of the FDA Oncologic Drug Advisory Committee’s Pediatric Subcommittee and the National Heart, Lung and Blood Institute Bone Marrow Transplant Clinical Trials Network Data and Safety Monitoring Board. For the past year, he has served as co-chair of the LLS PedAL initiative, a master clinical trial that will simultaneously test multiple targeted therapies for children who face a relapse of their acute leukemia. Dr. Kolb serves as the Principal Investigator on the Nemours Children’s Health System National Cancer Institute Community Oncology Research Program and the Delaware Comprehensive Sickle Cell Center of Biomedical Research Excellence. Among his clinical and research interests are bone marrow transplantation, acute myeloid leukemia (AML), and drug development for children with leukemias.